ArticleInternational journal of molecular sciences2023

Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.

Apostolia Papalexandri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.